Monthly Archives : February 2016


Valeant under investigation by SEC: Bloomberg

(Reuters) - Shares in embattled drugmaker Valeant Pharmaceuticals International Inc fell as much as 21 percent on Monday after Bloomberg reported that the company is under investigation by the U.S. Securities and Exchange Commision in a previously undisclosed probe.     
Continue Reading